A higher prediagnostic insulin level is a prospective risk factor for incident prostate cancer

  • Hammarsten J
  • Damber J
  • Peeker R
 et al. 
  • 20

    Readers

    Mendeley users who have this article in their library.
  • 18

    Citations

    Citations of this article.

Abstract

A higher insulin level has been linked to the risk of prostate cancer promotion. However, several reports claim that there is no association between a higher insulin level and the risk of incident prostate cancer. In the present report, the insulin hypothesis was tested once more prospectively in men with a benign prostatic disorder. Three hundred and eighty-nine consecutive patients referred with lower urinary tract symptoms without clinical prostate cancer were included during 1994-2002. Follow-up was performed in 2006. Data were obtained from the Swedish National Cancer Register and the Regional Cancer Register, Oncological Centre, Göteborg, Sweden. At this follow-up, 44 of the patients included had developed prostate cancer. Men with prostate cancer diagnosis had a higher systolic (P< 0.001) and diastolic blood pressure (P< 0.000), were more obese as measured by BMI (P= 0.010), waist (P= 0.007) and hip measurements (P= 0.041) than men who did not have prostate cancer diagnosis at follow-up. These men also had a higher uric acid level (P= 0.040), and a higher fasting serum insulin level (P= 0.023) than men who did not have prostate cancer diagnosis at follow-up. Following exclusion of T1a/b prostate cancer cases, the difference of the fasting serum insulin level between the groups was still significant (P= 0.038). Our data support the hypothesis that a higher insulin level is a promoter of prostate cancer. Moreover, our data suggest that the insulin level could be used as a marker of the risk of developing prostate cancer. The present findings also seem to confirm that prostate cancer is a component of the metabolic syndrome. Finally, our data generate the hypothesis that the metabolic syndrome conceals early prostate cancer. © 2010 Elsevier Ltd.

Author-supplied keywords

  • Benign prostatic hyperplasia
  • Hypertension
  • Insulin
  • Metabolic syndrome
  • Prostate cancer

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document

Authors

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free